Michel Gillard

The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes

Michel Noyer, Michel Gillard, Alain Matagne et al. · European Journal of Pharmacology · 1995 · 254 citations

Medicine, Neuroscience, Pharmacology +13

Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties

Michel Gillard, B. B. Fuks, Karine Leclercq et al. · European Journal of Pharmacology · 2011 · 248 citations

Medicine, Neuroscience, Pharmacology +11

Discovery of 4-Substituted Pyrrolidone Butanamides as New Agents with Significant Antiepileptic Activity

Benoît Kenda, Alain Matagne, Patrice Talaga et al. · Journal of Medicinal Chemistry · 2003 · 225 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Binding Characteristics of Cetirizine and Levocetirizine to Human H₁Histamine Receptors: Contribution of Lys¹⁹¹and Thr¹⁹⁴

Michel Gillard, Christy Van Der Perren, Nicole Moguilevsky et al. · Molecular Pharmacology · 2002 · 211 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

SV2A protein is a broad-spectrum anticonvulsant target: Functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy

Rafał M. Kamiński, Alain Matagne, Karine Leclercq et al. · Neuropharmacology · 2007 · 168 citations

Medicine, Neuroscience, Pharmacology +7